Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yusuke SAKAMAKI
Comparison of Health Costs Associated With Treatment of Hypertension With a Calcium Channel Blocker and Angiotensin-Converting Enzyme Inhibitor in the United States and Japan
Hypertension Research
Internal Medicine
Cardiovascular Medicine
Physiology
Cardiology
Related publications
Renal Outcomes in High-Risk Hypertensive Patients Treated With an Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Blocker vs a Diuretic
Archives of Internal Medicine
Effects of Angiotensin Converting Enzyme Inhibitor and Calcium Antagonist on Endothelial Function in Patients With Essential Hypertension.
Hypertension Research
Internal Medicine
Cardiovascular Medicine
Physiology
Cardiology
Lower Hospitalization and Healthcare Costs With Sacubitril/Valsartan Versus Angiotensin‐Converting Enzyme Inhibitor or Angiotensin‐Receptor Blocker in a Retrospective Analysis of Patients With Heart Failure
Journal of the American Heart Association
Cardiovascular Medicine
Cardiology
Genetic Variants Associated With Angiotensin-Converting Enzyme Inhibitor-Associated Angioedema
Pharmacogenetics and Genomics
Molecular Medicine
Genetics
Molecular Biology
Factors Associated With Hospitalization of Patients With Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema
Allergy and Asthma Proceedings
Medicine
Immunology
Pulmonary
Allergy
Respiratory Medicine
Race and Association of Angiotensin Converting Enzyme/Angiotensin Receptor Blocker Exposure With Outcome in Heart Failure
Journal of Cardiovascular Medicine
Medicine
Cardiovascular Medicine
Cardiology
Murine Recombinant Angiotensin-Converting Enzyme 2: Effect on Angiotensin II-Dependent Hypertension and Distinctive Angiotensin-Converting Enzyme 2 Inhibitor Characteristics on Rodent and Human Angiotensin-Converting Enzyme 2
Hypertension
Internal Medicine
Anticipated Combination of Beta-Blocker and Angiotensin-Converting Enzyme Inhibitor: New Opportunities for Optimizing Treatment of Cardiovascular Patients
HYPERTENSION
The Significance of Angiotensin Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker Use in Sudden Cardiac Death
International Journal of Clinical Medicine